Legal & General Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $729M | Sell |
|
|||||
|
2025
Q1 | $1B | Buy |
|
|||||
|
2024
Q4 | $912M | Sell |
|
|||||
|
2024
Q3 | $863M | Buy |
|
|||||
|
2024
Q2 | $687M | Buy |
|
|||||
|
2024
Q1 | $892M | Sell |
|
|||||
|
2023
Q4 | $857M | Sell |
|
|||||
|
2023
Q3 | $986M | Sell |
|
|||||
|
2023
Q2 | $1.11B | Buy |
|
|||||
|
2023
Q1 | $1.15B | Buy |
|
|||||
|
2022
Q4 | $1.19B | Buy |
|
|||||
|
2022
Q3 | $1.17B | Sell |
|
|||||
|
2022
Q2 | $1.31B | Buy |
|
|||||
|
2022
Q1 | $1.2B | Buy |
|
|||||
|
2021
Q4 | $947M | Sell |
|
|||||
|
2021
Q3 | $936M | Buy |
|
|||||
|
2021
Q2 | $1.01B | Buy |
|
|||||
|
2021
Q1 | $908M | Sell |
|
|||||
|
2020
Q4 | $897M | Buy |
|
|||||
|
2020
Q3 | $863M | Sell |
|
|||||
|
2020
Q2 | $868M | Sell |
|
|||||
|
2020
Q1 | $862M | Buy |
|
|||||
|
2019
Q4 | $977M | Buy |
|
|||||
|
2019
Q3 | $540M | Buy |
|
|||||
|
2019
Q2 | $480M | Buy |
|
|||||
|
2019
Q1 | $485M | Buy |
|
|||||
|
2018
Q4 | $445M | Buy |
|
|||||
|
2018
Q3 | $502M | Buy |
|
|||||
|
2018
Q2 | $441M | Sell |
|
|||||
|
2018
Q1 | $508M | Sell |
|
|||||
|
2017
Q4 | $520M | Sell |
|
|||||
|
2017
Q3 | $550M | Buy |
|
|||||
|
2017
Q2 | $470M | Buy |
|
|||||
|
2017
Q1 | $447M | Buy |
|
|||||
|
2016
Q4 | $460M | Sell |
|
|||||
|
2016
Q3 | $427M | Sell |
|
|||||
|
2016
Q2 | $583M | Buy |
|
|||||
|
2016
Q1 | $485M | Buy |
|
|||||
|
2015
Q4 | $515M | Buy |
|
|||||
|
2015
Q3 | $439M | Buy |
|
|||||
|
2015
Q2 | $473M | Sell |
|
|||||
|
2015
Q1 | $470M | Buy |
|
|||||
|
2014
Q4 | $427M | Sell |
|
|||||
|
2014
Q3 | $379M | Sell |
|
|||||
|
2014
Q2 | $373M | Buy |
|
|||||
|
2014
Q1 | $383M | Sell |
|
|||||
|
2013
Q4 | $399M | Sell |
|
|||||
|
2013
Q3 | $348M | Buy |
|
|||||
|
2013
Q2 | $335M | Buy |
|